0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query current partnering global cystic fibrosis partnering 2010 2017.Your search for "" gave back 1533016 results.
Fibroblast Growth Factor Receptor 4 - Pipeline Review, H2 2020 Summary Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) -...
Catalog:
Global Markets Direct
July 2020
Price: USD 3,500.00
Histone Deacetylase 3 - Pipeline Review, H1 2020 Summary Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Histone deacetylase 3 is...
Catalog:
Global Markets Direct
April 2020
Price: USD 3,500.00
Histone Deacetylase 1 - Pipeline Review, H1 2020 Summary Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Histone deacetylase 1 is an enzyme encoded by...
Catalog:
Global Markets Direct
April 2020
Price: USD 3,500.00
Anthrax - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anthrax -...
Catalog:
Global Markets Direct
July 2018
Price: USD 2,000.00
Anthrax - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anthrax -...
Catalog:
Global Markets Direct
January 2018
Price: USD 2,000.00
Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Drugs In Development, 2021 Summary According to the recently published report 'Histone...
Catalog:
Global Markets Direct
August 2021
Price: USD 3,500.00
Histone Deacetylase 2 - Pipeline Review, H1 2020 Summary According to the recently published report 'Histone Deacetylase 2 - Pipeline Review, H1...
Catalog:
Global Markets Direct
April 2020
Price: USD 3,500.00
Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H2 2018 Summary According to the recently published report 'Histone Deacetylase...
Catalog:
Global Markets Direct
September 2018
Price: USD 3,500.00
Vivus, Inc - Strategy, SWOT and Corporate Finance Report Summary Vivus, Inc - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
March 2022
Price: USD 175.00
Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Pipeline Review, H2 2018 Summary Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3...
Catalog:
Global Markets Direct
September 2018
Price: USD 3,500.00
Anthrax Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest...
Catalog:
Global Markets Direct
March 2022
Price: USD 2,000.00
Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H2 2018 Summary Transforming Growth Factor Beta 1 (TGFB1) pipeline Target constitutes...
Catalog:
Global Markets Direct
October 2018
Price: USD 3,500.00
C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update...
Catalog:
Global Markets Direct
September 2022
Price: USD 3,500.00
Sinusitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest...
Catalog:
Global Markets Direct
June 2022
Price: USD 2,000.00
RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Drugs in Development, 2021 Summary RAF Proto...
Catalog:
Global Markets Direct
November 2021
Price: USD 3,500.00
